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ABSTRACT
The tumour suppressor p53 is a transcription factor
that binds DNA in the vicinity of the genes it controls.
The affinity of p53 for specific binding sites relative
to other DNA sequences is an inherent driving force
for specificity, all other things being equal. We
measured the binding affinities of systematically
mutated consensus p53 DNA-binding sequences
using automated fluorescence anisotropy titrations.
Based on measurements of the effects of every
possible single base-pair substitution of a consen-
sus sequence, we defined the DNA sequence with
the highest affinity for full-length p53 and quantified
the effects of deviation from it on the strength of
protein–DNA interaction. The contributions of indi-
vidual nucleotides were to a first approximation
independent and additive. But, in some cases we
observed significant deviations from additivity.
Based on affinity data, we constructed a binding
predictor that mirrored the existing p53 consensus
sequence definition. We used it to search for high-
affinity binding sites in the genome and to predict
the effects of single-nucleotide polymorphisms in
these sites. Although there was some correlation
between the Kd and biological function, the spread
of the Kds by itself was not sufficient to explain the
activation of different pathways by changes in p53
concentration alone.
INTRODUCTION
The tumour suppressor p53 is responsible for inducing cell
cycle arrest or apoptosis under DNA-damaging condi-
tions in order to prevent dangerous accumulation of
mutations (1–3). The regulation of transcription by
p53 plays a critical role in cellular responses to carcino-
genic stimuli. p53 recognizes a 20bp DNA sequence
consisting of two repeats of RRRCWWGYYY (4),
separated by 0–13bp. Transcription factors speciﬁcally
recognize, on average, about half the nucleotides in the
binding site. Therefore, for a binding site of 10bp, one
would expect about a thousand (4
5) variants, and for a
binding site of 20bp this number is about one million (4
10).
Accordingly, one would expect to ﬁnd a few thousand
copies of 20bp and millions of 10bp binding sites in the
human genome. It is remarkable that transcription
regulation is as speciﬁc as it is, given the signiﬁcant
number of response elements for any one transcription
factor in the genome. A driving force for recognition of
speciﬁc binding sites is the aﬃnity of the transcription
factor for them in comparison with other DNA sequences
present in the genome. Diﬀerent sequences are recognized
by transcription factors with diﬀerent aﬃnity. It is
important to deﬁne the aﬃnity landscape, the distribution
of the aﬃnity values among all potential binding sites, in
order to understand the origins of speciﬁcity of a
transcription factor. This would allow rationalization of
the impact the variability of the binding sites or mutations/
modiﬁcations of the transcription factor have on regula-
tion of transcription. It is impractical to measure the
aﬃnity of every possible binding site. A way of identifying
binding sites and accurately predicting the aﬃnity of a
transcription factor for a given sequence is needed in order
to deﬁne the aﬃnity landscape.
The DNA recognition preference of a protein is usually
described by a ‘consensus’ sequence, which includes
possible variants of this sequence. Such a deﬁnition does
not quantify the detrimental eﬀects of deviation from the
consensus sequence, limiting its usefulness and predictive
power. Position weight matrix representation (5) is also
widely used to describe binding sites. The sites are deﬁned
based on the frequency of observing a particular base at a
particular position within the binding site, derived from a
set of known binding sites. The quality of position weight
matrices crucially depends on the availability of large
training datasets from experimentally observed binding
sites. Such datasets can be derived from chromatin (ChIP)
and DNA (DIP-Chip) immunoprecipitation assay, in vitro
evolution (SELEX) or protein-binding microarray
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ving a particular sequence was shown to be proportional
to the energy of interaction (9). Since the driving force for
the transcription factor to recognize a speciﬁc DNA
sequence is the energy of interaction, a number of
approaches were developed to directly determine the
contribution of individual nucleotide positions to the
overall binding. These methods included measuring
the aﬃnity of a transcription factor for a set of DNA
sequences using electrophoretic mobility shift assays
(EMSA) (QuMFRA), captured luciferase activity assay
or surface plasmon resonance (10–13). These powerful
methods can identify the consensus sequence and probe
the contribution of individual nucleotides in the DNA
binding. Unfortunately, these methods do not provide
an accurate estimate of the true protein–DNA aﬃnity
in solution because they rely on the surface immobiliza-
tion of the DNA probes or detect the interactions in the
gel media.
We developed an automation platform to multiplex
titration experiments to measure aﬃnities in solution with
high accuracy. Using ﬂuorescence anisotropy titrations,
we measured the eﬀects of every possible single base-pair
substitution of a consensus sequence on the aﬃnity of full-
length p53 for DNA and quantiﬁed the contribution of
individual nucleotides to the binding. The contributions of
individual nucleotides were practically additive which
allowed us to predict the aﬃnity of any potential binding
site for p53. We used this function to identify and predict
the aﬃnity of the tumour suppressor p53 for its potential
binding sites in the genome, and to predict the eﬀect of
single nucleotide polymorphism (SNP) variations in these
sites on p53 binding.
MATERIALS AND METHODS
We used the super-stable mutant of full-length p53
containing the following mutation in the core domain:
M133L/V203A/N239Y/N268D (14,15) of p53 as pseudo-
wt, which increased expression levels and sample stability.
It was puriﬁed as described earlier (16). All other reagents
were of highest grade available. Buﬀer conditions were
25mM NaPi, 225mM NaCl, 10% v/v glycerol, 5mM
DTT. Total ionic strength was 286mM. BSA (0.2mg/ml)
was added to buﬀers to minimize non-speciﬁc binding
of proteins at low concentrations when used with
plastic ware. DNA oligonucleotides were ordered from
Eurogentec, Belgium. Oligonucleotide concentration
was quantiﬁed by absorbance and normalized to 1mM
using epMotion 5070 pipetting robot (Eppendorf AG,
Germany) prior to annealing. They were annealed
by heating to 958C for 5min and cooling at 18C/min to
room temperature in the PCR block (PTC-100,
MJ Research, Inc., USA) and diluted to ﬁnal concentra-
tion of 50mM.
Fluorescence anisotropy measurements
DNA-binding experiments were done at 158C in the
Perkin Elmer LS50, Varian Eclipse and HoribaJobivYvon
Fluoromax-3 ﬂuorimeters using ﬂuorescence anisotropy
(16). The concentration of DNA was 1nM for direct
binding experiments and 20nM for competition experi-
ments. For competition experiments, 20nM Alexa488
labelled reference DNA was mixed with p53 to a ﬁnal
concentration of 120nM. A 50mM stock of competitor
DNA was added in small aliquots to compete the
reference DNA from the complex. Data were analysed
using laboratory software according to a competition
model. Measurements were multiplexed by performing
titrations on microtitre plates (Corning 3650) with Bravo
96-channel pipetting robot (Velocity11, USA) interfaced
with Pherastar plate reader (BMG LABTECH GmbH,
Germany) using 480/520nm ﬂuorescence polarization
module using manufacturer-provided software.
Titrations were done at room temperature 208C. The
sample volume during the titration was kept constant
(200ml) by aspirating the same volume of the sample
prior to addition of an aliquot of the competitor DNA.
In order to keep the concentration of reporter DNA and
protein constant, competitor DNA was mixed with the
same concentration of them as in the initial sample.
By this process, only the concentration of the competitor
DNA changes during the titration. To minimize the errors
associated with handling small volumes (<1ml), 2.5mM
stock of competitor DNA was used for the ﬁrst part
of the titration, switching to 25mM for second part.
Source microtitre plates were prepared using epMotion
5070 pipetting robot (Eppendorf AG, Germany).
Data were processed and analysed using laboratory-
developed software. Each titration was repeated at least
three times.
Data analysis
The change of the aﬃnity of interaction changes the
amount of protein bound to this site as follows:
Complex ¼ s
½P 
n
Kn
d þ½ P 
n 1
where [P] is the free concentration of the transcription
factor and Kd is the aﬃnity of interaction. While we do
not know the exact value of [P] in the cell, the ChIP
enrichment values are typically in the range of 1–10%,
meaning that binding sites are only partially saturated
in vivo. Therefore, we can assume that [P]<Kd. Under
such conditions, the amount of protein bound would
decrease as:
Complex 1
Complex 2
¼
K1
d
K2
d
   n
¼ 10 nlogKd 2
where n is the Hill constant of interaction which we have
previously shown to be 2, for p53 (17). The importance of
the co-operativity of interaction of the transcription factor
with DNA cannot be stressed enough. It magniﬁes the
eﬀects of the change in the Kd on the relative amount of
the protein–DNA complex formed. We converted the
observed changes in the Kd to the sequence logo (18)
(Figure 3).
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Since the dissociation constants in the above derivation
have dimensions of M
n, it is convenient to convert them
into dimension of M so that the meaning of the Kd is
concentration of protein at 50% saturation of the binding
sites.
K10 ¼ K11=n
K20 ¼ K21=n
½P þ
nA0½P 
n
K1m½P 
n þ
nB0½P 
n
K2m½P 
n   P0 ¼ 0
This equation could be solved numerically for [P].
Values of [A] and [APn] could be calculated from [P] and
used to deﬁne a ﬁtting function describing experimental
data.
r ¼ rA
½A 
A0
þ rAPn
½APn 
A0
RESULTS
A ‘binding predictor’ forp53
The energy of interaction of a protein with DNA G
consists of the sum of the energies of interaction of the
protein with individual base pairs Gi and is proportional
to the logarithm of the Kd and a loss of entropy of
association, TS.
G ¼
X
Gi   TS ¼  RTlnKd
By measuring the aﬃnity of a protein for all four
possible single-nucleotide permutations of the reference
consensus sequence at every position, it is possible to
assign a change logKd for every deviation from the
consensus sequence. If the contributions of individual
nucleotides are independent, the aﬃnity of the protein for
any given sequence of DNA can be calculated based on
the aﬃnity of the reference sequence and a sum of eﬀects
of substitution at every position.
Fluorescence anisotropy is the property of ﬂuorescent
molecules to retain the polarization of excitation light and
reﬂects the tumbling rate of molecules in solution. It is
ideal for studying protein–DNA interactions as the
complex formed is larger and tumbles more slowly than
the unbound oligonucleotide. The binding aﬃnity for the
ﬂuorescein-labelled reference sequence was determined
using direct ﬂuorescence anisotropy titrations as pre-
viously described (17). In subsequent experiments, we used
a competition assay (Figure 1) to improve the accuracy of
determination of a diﬀerence in the aﬃnity. The reference
sequence labelled with ﬂuorescein was mixed with p53
protein to form a complex, and unlabelled oligonucleotide
was added to the cuvette in small aliquots, to compete the
labelled oligonucleotide oﬀ. Analysis of the competition
curve allowed accurate determination of the diﬀerence in
the aﬃnities of the two oligonucleotides (Supplementary
Data).
After initial experiments, we have chosen a sequence
CGCGGACATGTCCGGACATGTCCCGC as a refer-
ence sequence (Table 1). It consists of the two identical
copies of the GGACATGTCC half-site, which is repre-
sentative of a consensus sequence RRRCWWGYYY,
ﬂanked by the CGC and CGC triplet to improve the
Figure 1. Fluorescence anisotropy R reﬂects the tumbling rate of
molecules in solution. It is ideal for studying strong protein–DNA
interactions as the complex formed is larger and tumbles more slowly
than the unbound oligonucleotide. A displacement of the reference
labelled oligonucleotide from the complex by the unlabelled oligonu-
cleotide allows accurate measurement of the diﬀerence in the Kd
between two sequences.
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the changes in the aﬃnity (Figure 2) caused by all possible
substitutions within the reference oligonucleotide, includ-
ing unlabelled reference sequence. Nucleotide substitu-
tions at some positions (e.g. 4) had larger eﬀects than at
other positions (e.g. 1 or 2). Diﬀerent nucleotide substitu-
tions at the same position also had diﬀerent eﬀects on the
aﬃnity of interaction (e.g. a base change A>C at position
3 compared to A>T). The substitution of the T>Ca t
position 8 resulted in increased aﬃnity, although the eﬀect
was negligible. This deﬁned the sequence with the highest
aﬃnity for p53 as GG(A/G)CATGCCCGGGCATG
(T/C)CC. The complete deﬁnition of the binding predictor
matrix is presented in Table 2, and its graphical
representation in Figure 3 (see Appendix 1 for details).
Since the second half-site, positions 11–20, mirrors the
ﬁrst half-site, only the ﬁrst one will be discussed. The
ﬂanking base pairs at positions 1, 2 and 10 had little
overall eﬀect on DNA binding as compared to other
positions. Position 1 does not form speciﬁc interactions
with DNA, and has little eﬀects on overall binding. p53
makes contacts with the nucleotide in position 2 via K120,
but the exact nature of this contact depends on the DNA
sequence (19). Non-speciﬁc recognition of oligonucleo-
tides is also true at the position 3, with preferred A/T/G at
the position 3 and C/T/A at position 8. Overall eﬀects on
binding at positions 3 and 8 are larger than at positions 1/
10, suggesting that these interactions, formed by C277,
play an important role in the DNA binding of p53. There
is a marked preference for a C at position 4 and G at
position 7. The G on the non-coding stand opposite to the
conserved C is recognized by R280. Large changes in Kd
induced by nucleotide substitutions at this position
suggest that these interactions are invariant. Even
though the nucleotide at position 5 does not make
contacts with p53 in the crystal structure, there is a
marked preference for A at this position, and T at position
6, which may be caused by DNA geometry constraints.
This preference is consistent with p53 transactivation data
(20). Interestingly, the exact contributions of the nucleo-
tides of the outer quarter site (positions 1–5) diﬀered from
those of the inner quarter site (positions 6–10) (Table 2).
This diﬀerence may be explained by domain–domain
interactions present in the two inner p53 core domains and
absent in the two outer ones (19).
Our data could be translated into consensus sequence of
a NDRCATGYYY or NNDCWWGYHN half-site,
depending on the threshold value selected. It is less
stringent than the existing deﬁnition of the p53 consensus
sequence RRRCWWGYYY (4). The most obvious
diﬀerences come from the selectivity of the ﬂanking
position 1, 2 and 10, and a preference for AT at positions
5/6. However, most known p53-binding sites deviate from
the consensus sequence (20). Our aﬃnity data correspond
well to the rules describing the transactivation activity of
p53 response elements: changes of conserved C or G
dramatically aﬀect activity; AT in the middle provides the
strongest activity; the eﬀects of deviation in the ﬂanking
RRR and YYY regions are stronger the closer they are to
the central CWWG motif. The consensus sequence
deﬁnition (4) is derived from only 20 sequences, which
were found to bind p53. While it certainly captures the
essence of the DNA-binding preferences of p53, relatively
small sample size and under-representation of weaker
binding sequences may explain the diﬀerences observed.
Figure 2. The eﬀects of individual substitutions in the reference
sequence on the aﬃnity of p53 for its response element. Positive bars
correspond to weaker interactions. Only ﬁrst 10bp of 20bp site are
shown because of the mirror symmetry of the response element. See
Table 1 for description of individual sequences. Reference sequence
bound p53 with the logKd of  7.51 (30nM).
Table 1. Oligonucleotide sequences used to construct binding predictor
Sequence
No.
Sequence Substitution
600 CGC GGACATGTCC GGACATGTCC CGC Ref
sequence
601 CGC AGACATGTCC GGACATGTCC CGC 1A
602 CGC TGACATGTCC GGACATGTCC CGC 1T
603 CGC CGACATGTCC GGACATGTCC CGC 1C
604 CGC GAACATGTCC GGACATGTCC CGC 2A
605 CGC GTACATGTCC GGACATGTCC CGC 2T
606 CGC GCACATGTCC GGACATGTCC CGC 2C
607 CGC GGTCATGTCC GGACATGTCC CGC 3T
608 CGC GGGCATGTCC GGACATGTCC CGC 3G
609 CGC GGCCATGTCC GGACATGTCC CGC 3C
610 CGC GGAAATGTCC GGACATGTCC CGC 4A
611 CGC GGATATGTCC GGACATGTCC CGC 4T
612 CGC GGAGATGTCC GGACATGTCC CGC 4G
613 CGC GGACTTGTCC GGACATGTCC CGC 5T
614 CGC GGACGTGTCC GGACATGTCC CGC 5G
615 CGC GGACCTGTCC GGACATGTCC CGC 5C
616 CGC GGACAAGTCC GGACATGTCC CGC 6A
617 CGC GGACAGGTCC GGACATGTCC CGC 6G
618 CGC GGACACGTCC GGACATGTCC CGC 6C
619 CGC GGACATATCC GGACATGTCC CGC 7A
620 CGC GGACATTTCC GGACATGTCC CGC 7T
621 CGC GGACATCTCC GGACATGTCC CGC 7C
622 CGC GGACATGACC GGACATGTCC CGC 8A
623 CGC GGACATGGCC GGACATGTCC CGC 8G
624 CGC GGACATGCCC GGACATGTCC CGC 8C
625 CGC GGACATGTAC GGACATGTCC CGC 9A
626 CGC GGACATGTTC GGACATGTCC CGC 9T
627 CGC GGACATGTGC GGACATGTCC CGC 9G
628 CGC GGACATGTCA GGACATGTCC CGC 10A
629 CGC GGACATGTCT GGACATGTCC CGC 10T
630 CGC GGACATGTCG GGACATGTCC CGC 10G
The sequence for the coding strand is shown. Oligonucleotides were
annealed with corresponding complementary oligonucleotides to form
double-stranded oligonucleotides.
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p53 consensus sequence (4,21), as well as empirical rules
describing active p53 response elements based on trans-
activation ability of p53 (20), are mirrored remarkably
well by the quantitative sequence logo. The main
improvement is quantiﬁcation of the eﬀect of sequence
variation on protein-recruiting ability.
Predicting the affinityof protein–DNA interactions
Assigning a change in the aﬃnity logKd to every
deviation from the reference sequence oﬀers a convenient
way of estimating the aﬃnity of a transcription factor for
any given DNA sequence:
logKdðxÞ¼logKdðrefÞþ
X
logKdði,NÞ 3
where x is the DNA sequence, logKd(ref) is the aﬃnity of
the reference sequence, and logKd(i,N) is the change in
the Kd induced by a nucleotide N substitution in the
ith position. The error of prediction accumulates over all
base pairs of the binding site. With an average error of
logKd determination of  0.05, one would expect an error
of prediction of  0.25.
We tested the accuracy of the logKd prediction by
comparing predicted aﬃnities with experimentally mea-
sured aﬃnities for naturally occurring response elements
(Figure 4 and Table 3). The native response elements
tested diﬀered from the reference sequence by 3–13
individual nucleotide substitutions. Some of the sequences
also had an extra base pair inserts between two half-sites
(Table 3). The predicted values were calculated using
laboratory-developed software according to the binding
predictor positional matrix in Table 2 and Equation (3).
Equation (3) implies independent contributions of the
individual nucleotide positions to the overall binding
aﬃnity. This assumption has been shown to hold reason-
ably well (22), even though there are examples where
nucleotides were not independent (23,24).
There was a clear correlation between the experimentally
measured and the predicted aﬃnity values. Interestingly,
the observed deviations were greater than experimental
error and corresponding errors in predicted aﬃnity values.
Non-speciﬁc binding of p53 to DNA may skew the
correlation between measured and predicted values. It is
2–3 orders of magnitude weaker than speciﬁc binding (25).
In our experiments, the weakest binding sequence had an
aﬃnity 1.5 orders of magnitude weaker than the reference
sequence. The aﬃnities of the majority of sequences were
within one order of magnitude of the reference sequence.
In addition, we did not observe clustering of the sequences
with weak experimentally measured aﬃnity, suggesting
that non-speciﬁc binding was not the reason for the
observed deviations.
Such deviations would also be observed if the contribu-
tions of the individual nucleotides were not completely
independent. The identity of the neighbouring nucleotides
may inﬂuence the contribution of a particular nucleotide.
Such behaviour would result in deviation from the
additive model. The accuracy of predictions was better
for high-aﬃnity sites (logKd< 6.9) than for lower aﬃnity
sites (logKd from  6.9 to  6.0), reﬂecting the fact that
they contain fewer deviations from the reference sequence.
The average deviation was 0.35 for all sequences tested
(70% were within this range). In extreme cases, there were
diﬀerences of up to 0.8 logKd units.
The presence of a spacer between the two half-sites adds
to the complexity of the p53 response elements. Based on
recent data (20,21), most functional p53 sites have an
insert length of 0 or 1. In our calculations, we have
Table 2. Binding predictor matrix deﬁnition
1234567891 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 1 9 2 0
Highest aﬃnity sequence G G A/G C A T G CCCGGGCATGT / A CC
A 0.05 0.03 0.00 0.59 0.00 0.16 0.55 0.25 0.15 0.12 0.03 0.10 0.05 0.62 0.00 0.21 0.31 0.15 0.10 0.07
T 0.07 0.10 0.15 0.31 0.21 0.00 0.62 0.05 0.10 0.03 0.12 0.15 0.25 0.55 0.16 0.00 0.59 0.00 0.03 0.05
G 0.00 0.00 0.00 0.55 0.28 0.35 0.00 0.47 0.29 0.13 0.00 0.00 0.00 0.61 0.32 0.47 0.00 0.40 0.18 0.11
C 0.11 0.18 0.40 0.00 0.47 0.32 0.61 0.00 0.00 0.00 0.13 0.29 0.47 0.00 0.35 0.28 0.55 0.00 0.00 0.00
Each cell contains a diﬀerence logKd between the oligonucleotide containing a single substitution indicated in a row header and the tightest binding
sequence. The highest aﬃnity sequence shown in the top row had a logKd of  7.61.
Figure 3. Quantitative sequence logo of the p53 DNA-binding
preferences. The height of the bars represents the number of times by
which the amount of protein bound decreases, due to the base
substitution. It shows the biggest possible eﬀect caused by three
alternative substitutions. The height of individual letters is proportional
to the amount of transcription factor bound to individual sequence
variants under identical conditions. The sequence of the second half-site
is identical to the ﬁrst one when read on the non-coding strand of
DNA in the 50–30 direction. The sequence logo takes complementarity
of DNA into account. The sequence with the highest aﬃnity for p53 is
GG(A/G)CATGCCCGGGCATG(T/C)CC.
Nucleic Acids Research, 2008, Vol. 36, No. 5 1593assumed that the presence of an insert does not aﬀect the
aﬃnity. The aﬃnities of the IGF-BP3 and Bax A response
elements with a one base-pair insert were correctly
predicted, supporting this assumption. We did not test
sites with longer spacers between half-sites.
The observed deviations from the additive model suggest
that the contributions of individual nucleotides are not
100% independent. The ﬁrst-order additive model is accu-
rate for high-aﬃnty sites (logKd< 6.9) and is a useful
approximation for lower aﬃnity sites (logKd> 6.9),
providing accurate estimates in 70% of cases. The use-
fulness of such prediction for the lower aﬃnity sites
depends on the context in which they are used. The binding
predictor software, together with the deﬁnition of the
p53-binding matrix, is available for download from our
website (www.mrc-cpe.cam.ac.uk).
Search forhigh-affinity response elements in thegenomic
DNA sequence
Ability to predict the aﬃnity of the transcription factor for
any DNA sequence oﬀers a convenient way of searching
for high-aﬃnity sites in the genome. We calculated the
aﬃnity for a binding site located at every nucleotide
position in the genome. A small portion of a genomic
sequence surrounding known p53-binding site in the
promoter of a p21 gene is shown in Figure 5. Two
features are evident from this ﬁgure. The known p53
response element is easy to identify as the tightest binding
site. p53 could also bind at any position within this stretch
of DNA, with a signiﬁcantly lower aﬃnity. This is not
surprising as p53, and transcription factors in general, do
form both speciﬁc and non-speciﬁc (backbone) contacts
with DNA, and have aﬃnity for non-speciﬁc DNA. The
exact number of identiﬁed high-aﬃnity binding sites in the
human genome increases exponentially with increase in
the cutoﬀ value for the logKd selected (Figure 6).
We located over 10000 high-aﬃnity sites with a
predicted logKd< 6.9, and over 200000 weaker sites
(logKd< 6.5). The error in the logKd prediction for the
low-aﬃnity sequences will not signiﬁcantly aﬀect the total
number of sites identiﬁed because the number of sites with
their logKd value either under-estimated or over-estimated
will be comparable.
A well-documented site in the promoter region of
CDKN1A (p21), known p53 target, was in the top 6000
sites ranked according to predicted aﬃnity. Interestingly,
a promoter region of p73, a paralogue of p53, also
contained a high-aﬃnity site. Some other known p53
targets, such as MDM2 and BAX, on the other hand,
contained binding sites with weaker aﬃnities. An analysis
of 100 documented p53-binding sites (summarized in 26),
presented in Table S1, suggested that there are large
variations in the logKd values for sites regulating genes
with similar functions. The binding sites in the promoter
regions of genes controlling DNA repair ( 7.1 0.3) and
Figure 4. Correspondence of the measured and predicted aﬃnities of
naturally occurring response elements. Black line represents ‘perfect’
prediction.
Table 3. Oligonucleotide sequences used to test predicted logKds
Name of the promoter Sequence(29) logKd (expected) logKd (predicted)
Cyclin G CGCAGACCTGCCCGGGCAAGCCTCGC  7.02  6.83
14-3-3s CGCAGGCATGTGCCACCATGCCCCGC  6.85  6.52
CDK1NA (p21) 30 site CGCGAAGAAGACTGGGCATGTCTCGC  6.9  6.54
p53R2 CGCTGACATGCCCAGGCATGTCTCGC  7.35  7.46
PCNA CGCGAACAAGTCCGGGCATATGTCGC  6.82  6.83
Maspin CGCGAACATGTTGGAGGCCTTTTGCGC  6.89  6.19
PUMA BS2 CGCCTGCAAGTCCTGACTTGTCCCGC  6.88  6.86
Noxa CGCAGGCTTGCCCCGGCAAGTTGCGC  6.93  6.87
p53AIP1 CGCTCTCTTGCCCGGGCTTGTCGCGC  6.92  6.73
Bax A CGCTCACAAGTTAGAGACAAGCCTCGC  6.67  6.59
IGF-BP3 CGCAAACAAGCCACCAACATGCTTCGC  6.77  6.89
p53DINP1 CGCGAACTTGGGGGAACATGTTTCGC  6.78  6.25
PUMA CGCCTCCTTGCCTTGGGCTAGGCCCGC  6.8  5.99
rad51 AAACTCGCGCAGGATCAAGCTCT  5.96  6.12
PA26 GGACAAGTCTCAACAAGTTC  6.47  6.85
Bax B AGACAAGCCTGGGCGTGGGC  6.24  6.47
MMP2 AGACAAGCCTGAACTTGTCT  6.39  7.01
CDK1NA (p21) 50 site CAACATGTTGGGACATGTTC  7.14  7.11
MDM2_RE1 GGTCAAGTTGGGACACGTCC  6.47  6.69
MDM2_RE2 GAGCTAAGTCCTGACATGTCT  6.41  6.42
1594 Nucleic Acids Research, 2008, Vol. 36, No. 5the death receptor ( 7.0 0.2) pathways contained higher
aﬃnity sites as compared to apoptotic pathway
( 6.6 0.3). However, the distribution of logKd values
predicted for various pathways overlapped (Table S1).
Moreover, the human genome contains a large number of
putative sites with similar aﬃnity. One order of magnitude
change from the highest aﬃnity sequence results in over
200000 predicted binding sites in the genome, and a p53-
binding site in the promoter region of almost every gene.
A list of all the p53-binding sites identiﬁed in the genome,
and a list of the corresponding genes which have at least
one binding site within 100kb distance is available from
our website.
Predicting the effectof SNPs
SNP is a natural nucleotide variation between individuals.
If such variation is in the binding site of a transcription
factor, it may aﬀect the transcription control. SNP
represent a special case for the binding predictor. Since
it is a single-nucleotide substitution, the accuracy of
prediction is very good because the error does not
accumulate over the whole binding site. We analysed the
NCBI dbSNP database (http://www.ncbi.nlm.nih.gov/
projects/SNP/) and identiﬁed 19355 SNPs which are
located in putative p53-binding sites, where at least one
of the polymorphic variants fulﬁls our criteria for a high-
aﬃnity binding site (logKd <  6.5) and was predicted to
aﬀect the p53 binding by more than a factor of 3
[Equation (2)]. Out of these, 5142 were predicted to
aﬀect the binding of p53 by more than a factor of 10. In a
recently reported example, a C to T SNP variation in the
ﬂt-1 promoter of the VEGF system makes it responsive to
p53 and incorporates it into p53 pathway (27). We
predicted a change in the logKd from  6.46 to  6.78,
which corresponds to a 4-fold increase in the amount of
p53 bound to this site. The predicted increase is in
excellent agreement with the experimental data reported
(27). A database of SNPs with p53 recognition sites and
predicted eﬀects is on our website.
DISCUSSION
Matrices are widely used to describe the relationship
between a nucleotide sequence and its functional activity
(5,28). The elements of the matrix corresponding to the
bases in the sequence are added to calculate a score, and
any sequence could be assigned 1. The quality of this
relationship deﬁnition and the predictive value of the
matrix are determined by the accuracy of the method used
to assign individual values. We experimentally measured
the eﬀect of single-nucleotide substitutions on the
p53–DNA aﬃnity. Fluorescence anisotropy titrations
provided accurate aﬃnity values of interaction in solution.
We used these values to construct the ‘binding predictor’
positional matrix. The elements of the matrix are the
diﬀerences in the logKd value caused by a particular
nucleotide substitution. The logKd value is proportional to
the binding energy of interaction. The calculated score is
the logarithm of the dissociation constant.
In order to have a manageable number of measure-
ments, we minimized the sequence space coverage. We
restricted it to the single-point mutants of the representa-
tive consensus sequence, assuming the case of independent
and additive contributions. It is possible that the change in
the neighbouring nucleotides could aﬀect the nucleotide
binding preferences of the position in question. We
compared, therefore, the calculated values with experi-
mentally determined values for a set of known response
elements containing multiple nucleotide substitution
(Figure 4, Table 3).
We experimentally tested sequences with logKd up to
 6.0. The deviation of predicted values from experimen-
tally measured ones was greater than that of the expected.
This suggests that the individual nucleotides do not make
completely independent contributions to the overall
binding. For example, the PUMA response element was
predicted to have much weaker aﬃnity than the experi-
mentally measured one by logKd of 0.8. The average
deviation of predicted ones from measured values was 0.35
for all sequences tested, which means that the aﬃnity of
Figure 5. A plot of p53 aﬃnity for DNA as a function of bp position.
A 50bp region around the 50 p53-binding site, 2209bp upsream of the
CDK1NA (p21) gene is shown (Chr6: 36752204:36752223 in NCBI 36.2
genome release). The circle marks the known p53-binding site.
Figure 6. Number of putative p53-binding sites of the length of 20 or
21bp identiﬁed in the human genome (release 36.2) grows exponentially
with increasing cutoﬀ value.
Nucleic Acids Research, 2008, Vol. 36, No. 5 159570% of sequences was predicted within a factor of 2. The
accuracy of predictions was better for high-aﬃnity sites
(logKd< 6.9) than for lower aﬃnity sites (logKd from
 6.9 to  6.0), reﬂecting the fact that they contain fewer
deviations from the reference sequence. The quality of
prediction may be improved by using more ﬁne-grained
models, e.g. measuring the eﬀect of every possible
dinucleotide substitution, at the expense of the exponen-
tially increasing number of measurements necessary.
Overall, the ﬁrst-order additive model is accurate for
high-aﬃnity sites (logKd< 6.9) and provides a useful
approximation for lower aﬃnity sites (logKd> 6.9).
The dissociation constants for native response elements
measured in this study diﬀer from those we reported
earlier (29). There were changes in absolute values, as well
as changes in the relative values of dissociation constants
(Figure S1). Most notably, the range in aﬃnity values
reported is smaller in the present study. However, we used
diﬀerent buﬀer conditions, a diﬀerent format of binding
experiments, and diﬀerent protein constructs. The changes
in absolute values can be explained by the changes in the
buﬀer conditions. Protein–DNA interactions are electro-
statically driven and are very sensitive to changes in the
ionic strength. In our present study, we used buﬀer
conditions with higher ionic strength (I=286mM versus
I=225mM), which resulted in lower absolute aﬃnity
values. We used a competition format for binding
experiments instead of direct binding. This resulted in
greater accuracy of measurements. The dynamic range of
the competition experiments (1.5–2 orders of magnitude
relative to the reference sequence) was suﬃcient to reliably
measure the values reported. In the present study, we used
full-length p53 as opposed to the construct containing the
DNA binding and tetramerization domain we had used
earlier (29). The presence of the ﬂanking N-terminal and
C-terminal domains could result in the altered DNA-
binding preferences of the protein, and in particular, in
increased binding to the weaker response elements. The
current measurements reﬂect the DNA-binding properties
of full-length p53.
Ability to predict the aﬃnity of p53 to any DNA
sequence permits the search for high-aﬃnity sites in the
genome by calculating the aﬃnity for every position, the
very property that governs the transcription factor binding
toresponseelements.Thenumberofpredictedp53-binding
sites increases exponentially with an increase in the aﬃnity
cutoﬀ value (Figure 6). We analysed the positioning of the
identiﬁed putative binding sites relative to the transcription
start sites. The sites were evenly distributed in the genome,
with no marked tendency to cluster around transcription
start sites. Interestingly, most established binding sites are
located close to the transcription start sites (30). This
apparent diﬀerence could be explained by involvement of
other cellular factors in the selection of functional binding
sites from all possible putative binding sites.
As with any other ranking functions, it is important to
decide what aﬃnity value represents a genuine binding
site, and what values are irrelevant or not important.
For example, only the highest aﬃnity sites representing
the desired total number (e.g. top 500) may be included,
and the corresponding aﬃnity cutoﬀ value could be
determined (Figure 6). Alternatively, the aﬃnity values
can be compared with the aﬃnity of the previously
documented binding sites. The set of binding sites
identiﬁed experimentally using chromatin immunopreci-
pitation assay (ChIP) can also be compared with the set of
putative binding sites selected based on their aﬃnity.
The examination of p53-binding sites using ChIP of 1%
of the human genome, as part of the ENCODE project,
identiﬁed 37 p53-binding sites, which can be extrapolated
to  3700 sites genome wide (31). The analysis of p53
binding to chromosomes 21 and 22 (circa 3% of the
genome) (32) identiﬁed 48 binding sites, which can be
extrapolated to 1500 binding sites genome wide. Genome-
wide analysis identiﬁed 542 p53-binding sites (21). The
same number of binding sites could be selected by
imposing a logKd cutoﬀ value of  7.1,  7.2 and  7.3,
on our data (Figure 6). The diﬀerence in the number of
binding sites identiﬁed may be explained by a diﬀerence in
the stringency of selection criteria employed. However, the
236 sites with insert length of 0 between half-sites
identiﬁed in the genome-wide ChIP experiment (21) have
logKd values in the range  7.5 to  6.93. We identiﬁed
over 8500 putative binding sites with similar aﬃnity in the
genome. Furthermore, there was only 7% overlap between
our highest aﬃnity 230 putative binding sites and the 236
ChIP-identiﬁed sites.
These cutoﬀ values compare well with aﬃnities of the
p53 response elements controlling known p53 target genes
p21 ( 7.11) and p53R2 ( 7.46). However, such a
stringent selection criterion misses a number of known
p53 target sites. Mdm2, the negative regulator of p53 and
a known p53 target gene, has multiple binding sites for
p53 with a logKd in the range around  6.69. Multiple
weak binding sites can behave as one strong site if binding
to any of them results in increased transcription.
Unfortunately, it is not known if the binding sites in
mdm2 promoter are synergetic. The known p53-binding
site in the promoter region of the BAX gene has an even
weaker aﬃnity with a logKd of  6.59. Given the large
number of sites with comparable aﬃnity in the genome
(circa 200000 with an insert length of 0 or 1), speciﬁc
transcription activation of mdm2 and BAX by p53 cannot
be explained based on the aﬃnity of p53 to DNA alone.
Manyofknownexperimentallyveriﬁedp53-bindingsites
hadthepredictedvalueoftheKd1–1.5ordersofmagnitude
weaker than the sequence with highest aﬃnity (Table S1).
The Kd value may play a role in the activation of the target
gene: the genes with tighter binding sites should respond
stronger to the changes in p53 concentration caused by
carcinogenic stress. Indeed, there is some correlation
between the biological pathway of the gene and the
strength of the site (Table S1). The binding sites controlling
genes involved in DNA repair and the death receptor
pathway were predicted to be the strongest, and sites
involved in apoptosis and negative regulation were the
weakest. The sites controlling genes cell cycle and mitosis
had intermediate logKd values. Large variations in the
logKd values resulted in the overlap of the distribution of
aﬃnities of sites controlling diﬀerent pathways. It is very
unlikely that changes in p53 concentration alone could
explain the speciﬁcity of activation of diﬀerent pathways in
1596 Nucleic Acids Research, 2008, Vol. 36, No. 5response to carcinogenic stress, e.g. cell cycle arrest
versus apoptosis. In addition, there are hundreds of
thousands putative sites of similar aﬃnity in the human
genome.
It is clear that p53 recognizes sites in DNA whose
sequence resembles the canonical p53-binding site, and
for which it has a marked preference compared with
the surrounding sequence. The fact that only a small
fraction of all possible sites with aﬃnities similar to those
identiﬁed in the ChIP experiment is occupied in the cell
(and a small fraction needs to be occupied for transcrip-
tion regulation to have any speciﬁcity), suggests that there
are other factors controlling the selection of binding sites.
Changes in the chromatin state, for example, may result
in only a small percentage of potential p53-binding
sites being accessible at a given time. The alternative
possibility is that p53 functions together with another
transcription factor(s) which has a binding site in close
proximity (33). Even weak protein–protein interactions
would dramatically increase the apparent aﬃnity of both
p53 and its partner for DNA and provide the basis for
selection. Such co-operative binding could provide a
mechanism for selection of one site over other potential
binding sites.
With over 10 million individual SNPs documented in
the human genome, it is not surprising that some of them
are in the binding sites of transcription factors. The SNP
may aﬀect the binding of a transcription factor, disturb
the functioning of a particular pathway, and pre-dispose
an individual to a development of a disease. The binding
predictor is ideally suited for predicting the eﬀect of SNP
in the binding site of p53. The relative eﬀect of the SNP
will remain the same even if the absolute aﬃnity of a
transcription factor for DNA is aﬀected by other cellular
factors. Assuming that 1% of the predicted binding sites
are physiologically relevant, we estimated that around 200
SNPs would aﬀect the p53 binding (>3-fold diﬀerence),
and around 50 would aﬀect it dramatically (>10-fold).
It is a signiﬁcant proportion of the estimated 500–3000
p53-binding sites existing in the cell.
The systematic study of the protein–DNA interactions
by single-point mutations in consensus DNA sequence
accessed by accurate measurements of aﬃnity in solution
using ﬂuorescence anisotropy is a powerful way to
describe the DNA binding preferences of a transcription
factor. Using this method, we deﬁned the DNA sequence
with the highest aﬃnity for p53 and quantiﬁed the eﬀect of
deviations from this sequence on the strength of the
interaction. This method allows prediction of p53-binding
aﬃnity for any potential response element in the genome,
all other things being equal. The binding predictor can
identify potential p53-binding sites in the genome and
predict the eﬀects of SNPs on these interactions, and is
applicable to the study of the DNA-binding speciﬁcity of
any transcription factor.
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APPENDIX 1
Sequence logoconstruction
The relative height of individual nucleotide bar at each
position reﬂects the amount of protein bound to the
sequence relative to the highest aﬃnity sequence as deﬁned
by Equation (2)
Pði,NÞ¼10 nlogKdði,NÞ A:1
Where i is the position of the nucleotide, N is its identity
(A,T,G,C), n is the Hill coeﬃcient and logKd(i,N) is the
change in the logKd taken from the binding matrix
(Table 2).
The overall height of the bar at each position is
determined by the nucleotide substitution which causes
the largest change in the logKd and results in the smallest
amount of protein bound.
hðiÞ¼
1
minðði,NÞÞ
A:2
Combining Equations (A.1) and (A.2), the heights of the
individual nucleotide bars are calculated as follows:
h0ði,NÞ¼
hiÞPði,NÞ
P c
N¼A
Pði,NÞ:
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